Low Intrahepatic Distant Recurrence Rate Following RFA Using Linear Mode in Patients With Hepatocellular Carcinoma

Documenti analoghi

• Dual Escape From Ferroptosis and Disulfidptosis Denotes a Hypermetabolic, High‐Risk Subtype of Hepatocellular Carcinoma
  di: Tadashi Namisaki, et al.
  Pubblicazione: (2026)
• Prediction of Hepatocellular Carcinoma After Direct‐Acting Antiviral Therapy Using Agile 3+ and End‐of‐Treatment Alpha‐Fetoprotein Levels in Patients With Hepatitis C
  di: Akifumi Kuwano, et al.
  Pubblicazione: (2025)
• Differences in Endoscopic Features of Gastric Neuroendocrine Tumor and Neuroendocrine Carcinoma From a Clinicopathological Perspective
  di: Katsunori Matsueda, et al.
  Pubblicazione: (2025)
• Effect of Butyrate‐Producing Enterobacteria and Proton Pump Inhibitors on Advanced Hepatocellular Carcinoma Treatment With Durvalumab and Tremelimumab
  di: Kazuhiro Nouso, et al.
  Pubblicazione: (2026)
• Electrohydraulic Lithotripsy for Hepatolithiasis With Novel VedVision Cholangioscope and New Biodegradable Stent ( UNITY ‐B) for Intrahepatic Biliary Stricture: A Case Report With Video
  di: Davide Scalvini, et al.
  Pubblicazione: (2025)